<DOC>
	<DOCNO>NCT01293760</DOCNO>
	<brief_summary>The purpose study determine , pilot setting , study feasible term recruitment , willingness randomize , provision contraceptive method , follow-up . The investigator hypothesize pilot study feasible term recruitment , provision care , follow-up . The study pilot randomize control trial compare outcome immediate post-placental insertion Copper T 380A ( Group 1 ) outcome interval insertion Copper T 380A perform 6 week delivery ( Group 2 ) patient undergo schedule cesarean delivery Mulago Hospital Kampala , Uganda . This study power detect difference , rather investigator enroll eligible interested woman three-month enrollment period . Potential participant choose IUD choose participate offer anonymous opt-out survey .</brief_summary>
	<brief_title>Immediate Post-placental Insertion Copper T 380A After Cesarean Delivery Versus 6 Week Post-cesarean Insertion</brief_title>
	<detailed_description />
	<mesh_term>Copper</mesh_term>
	<criteria>1 . Pregnant time enrollment 2 . Scheduled undergo nonemergent cesarean delivery 3 . Will wait least 8 hour cesarean section 4 . Are active labor 5 . Desires use Copper T 380A contraception 6 . Willing able sign inform consent 7 . Willing comply study protocol 8 . Age great equal 18 year 9 . English Luganda speak 10 . Willing accompany home upon discharge hospital address record order able visit home 6 month postpartum return 6 month followup visit . 1 . Allergy copper pelvic tuberculosis , severe thrombocytopenia 2 . Positive N. gonorrheae C. trachomatis test 3 . Presence leiomyomata significantly distort uterine cavity thus allow placement Copper T 380A 4 . Uterine anomaly would allow placement Copper T 380A 5 . Current cervical cancer carcinoma insitu 6 . Desire repeat pregnancy le 12 month 7 . Evidence intrauterine infection ( Chorioamnionitis ) 8 . Preterm birth prior 34 week gestation 9 . Diagnosis AIDS ( HIV exclusion criterion ) 10 . Fetal demise 11 . Antepartum hemorrhage 12 . Ruptured uterus 13 . Eclampsia 14 . Evidence severe anemia Post enrollment exclusion criterion 1 . Group 1 : Interval development exclusion criterion ( New evidence chorioamnionitis ; fetal demise ; rupture uterus ; eclampsia ; severe anemia ) 2 . Group 1 : Postpartum hemorrhage continue active bleeding allow placement Copper T 380A within 10 minute delivery placenta 3 . Group 1 : Prolonged rupture membrane &gt; 12 hour 4 . Group 2 : Diagnosis active cervical infection within 3 month plan insertion , evidence active pelvic cervical infection , pus cervical o concern upper genital tract infection , include fever ( temperature ≥ 38° C ) uterine adnexal tenderness . Diagnosis new pregnancy . 5 . Group 2 : Interval development exclusion criterion ( i.e . new suspicion cervical cancer carcinoma situ ) 6 . Both Groups : Participant long desire Copper T 380A</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>intrauterine device</keyword>
	<keyword>contraception</keyword>
</DOC>